Clinical trial
Effects of Inhibition of NO-Synthesis on Renal Hemodynamics and Sodium Excretion…
NCT00345150 · Regional Hospital Holstebro, Other · Completed
Key facts
| NCT number | NCT00345150 |
|---|---|
| Title | Effects of Inhibition of NO-Synthesis on Renal Hemodynamics and Sodium Excretion in Patients With Essential Hypertension and Healthy Controls |
| Official title | Phase 1 Study of the Effects of Systemic Nitric Oxide Inhibition With Ng-Monomethyl-L-Arginine on Renal Hemodynamics and Sodium Excretion in Patients With Essential Hypertension and Healthy Controls |
| Lead sponsor | Regional Hospital Holstebro, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Ng-monomethyl-L-arginine (drug) |
| Enrollment | 30 |
| First posted | Jun 27, 2006 |
| Last update posted | Jun 27, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: